(POSC.OB) Positron Corporation Is Scheduled To Present At Rodman & Renshaw Annual Global Investment Conference

(PublicWire.com Medical News Release)Positron Corporation (OTCBB:POSC), a molecular imaging and solutions company specializing in nuclear cardiology and a leader in cardiac PET, announced today the Company is scheduled to present at the Rodman & Renshaw Annual Global Investment Conference, held on September 12-15, at the New York Palace hotel in New York City.

Patrick Rooney, chief executive officer of Positron Corporation, will be presenting on Tuesday, September 14th. Details surrounding the presentation and audio webcast will be made available in the coming weeks.

For more information about the Rodman & Renshaw 12th Annual Healthcare Conference, go to: http://www.rodmanandrenshaw.com/conferences.

(POSC.OB) Positron Corporation Is Scheduled To Present At Rodman & Renshaw Annual Global Investment Conference

About Positron: Positron is a molecular imaging company focused on Nuclear Cardiology. Positron utilizes its proprietary product line to provide unique solutions to the Nuclear Medicine community ranging from imaging to radiopharmaceutical distribution. Positron products include: the Attrius, a PET imaging device; the Pulse , a SPECT imaging device; the Nuclear Pharm-Assist , an automated radiopharmaceutical distribution device; and the Tech-Assist, a radiopharmaceutical injection shield. More information about Positron is available at www.positron.com.

POSC.OB, POSC.OTCBB, OTCBB:POSC, POSC

For more information, and to be better informed in your decision making process, check out a detailed profle of POSC’s perfomance.

Forward Looking Statements

Certain statements in this press release that are not historical facts are “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements may be identified by the use of words such as “anticipate, “believe,” “expect,” “future,” “may,” “will,” “would,” “should,” “plan,” “projected,” “potential,” “intend,” and similar expressions. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the “company to be materially different from those expressed or implied by such forward-looking statements.

For all the latest in small cap news, videos, and information, visit us online at PublicWire.com, or call us, toll free, at 888-843-1412.

Tags: ftd, Medical, OTCBB:POSC, POSC, POSC.OB, POSC.OTCBB, Positron Corporation, Rodman & Renshaw Annual Global Investment Conference